Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP414167.RA658bI9FVZQ5MB1oybFS20xhKMMiBTrEg4pYL0HPt0R0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414167.RA658bI9FVZQ5MB1oybFS20xhKMMiBTrEg4pYL0HPt0R0130_assertion type Assertion NP414167.RA658bI9FVZQ5MB1oybFS20xhKMMiBTrEg4pYL0HPt0R0130_head.
- NP414167.RA658bI9FVZQ5MB1oybFS20xhKMMiBTrEg4pYL0HPt0R0130_assertion wasGeneratedBy ECO_0000203 NP414167.RA658bI9FVZQ5MB1oybFS20xhKMMiBTrEg4pYL0HPt0R0130_provenance.
- NP414167.RA658bI9FVZQ5MB1oybFS20xhKMMiBTrEg4pYL0HPt0R0130_assertion wasDerivedFrom befree-20150227 NP414167.RA658bI9FVZQ5MB1oybFS20xhKMMiBTrEg4pYL0HPt0R0130_provenance.
- NP414167.RA658bI9FVZQ5MB1oybFS20xhKMMiBTrEg4pYL0HPt0R0130_assertion SIO_000772 22523595 NP414167.RA658bI9FVZQ5MB1oybFS20xhKMMiBTrEg4pYL0HPt0R0130_provenance.
- NP414167.RA658bI9FVZQ5MB1oybFS20xhKMMiBTrEg4pYL0HPt0R0130_assertion evidence source_evidence_literature NP414167.RA658bI9FVZQ5MB1oybFS20xhKMMiBTrEg4pYL0HPt0R0130_provenance.
- NP414167.RA658bI9FVZQ5MB1oybFS20xhKMMiBTrEg4pYL0HPt0R0130_assertion description "[The drug has shown a high selectivity for myxoid liposarcoma, characterized by the translocation t(12;16)(q13; p11) leading to the expression of FUS-CHOP fusion gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414167.RA658bI9FVZQ5MB1oybFS20xhKMMiBTrEg4pYL0HPt0R0130_provenance.